Advertisement Bioenergy and Integrative Therapeutics sign marketing alliance - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Bioenergy and Integrative Therapeutics sign marketing alliance

Bioenergy Life Science and Integrative Therapeutics have entered into a co-marketing alliance under which Integrative Therapeutics will now sell the Corvalen line of products, developed by Bioenergy Life Science, to its established health care practitioners.

Clinical research has shown that medical food Corvalen (D-ribose) provides metabolic support to accelerate cellular energy recovery and normal cellular functioning for patients with chronic fatigue syndrome and fibromyalgia, Bioenergy said.

Tom VonderBrink, president and chief operating officer of Bioenergy
Life Science, said: “We are thrilled about the agreement with this quality leading company as it quadruples the number of representatives educating health care practitioners on the value of this significant emerging therapy.

“D-ribose is already changing the lives of many suffering from chronic energy-depleting conditions. It’s also improving the quality of life for baby boomers as they reach the prime of their lives. Our collaboration will mean that more people will have access to this exciting breakthrough.”